Metastatic Breast Cancer
Relevance: Medium-High
Most relevant for: People with advanced HER2-positive cancer
Topic: The drug Enhertu is FDA-approved for any advanced or metastatic HER2-positive tumors
The FDA granted accelerated approval of Enhertu for people with any HER2-positive tumor that is metastatic or cannot be surgically removed. Eligible patients must have had previous treatment such as chemotherapy or hormone therapy. (Posted 7/19/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: Cancer patients
Topic: Experts call for early palliative care for cancer patients
People with cancer need support and care not only at the end of life but from the time of diagnosis. At the 2024 American Society of Clinical Oncology (ASCO) annual meeting, the organization’s president urged cancer healthcare professionals to make palliative care central to cancer treatment. (Posted 7/17/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Most relevant for: People diagnosed with cancer who have not yet had genetic testing
Study: Genetic testing among people with cancer can find mutations that may affect treatment and prevention
Despite national guidelines recommending genetic testing, less than 10 percent of eligible patients had genetic testing within two years after their cancer diagnosis. Among those who had testing, 10-30 percent had an inherited mutation that could affect their medical care. (Posted 3/15/2024)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium
Most relevant for: People with HR-positive and HER2-negative metastatic breast cancer. People with silicone breast implants. People considering thermography screening
Update: News from the FDA– new breast cancer treatment, thermography warning and implant screening updates
This XRAY review is a summary of FDA breast cancer updates from July to December 2023. This includes a new drug approval and two consumer updates. (Posted 2/21/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: People with hormone receptor (HR)-positive or HER2-negative breast cancer that has spread outside the breast tissue.
Update: New drug combination for the second treatment of some HR-positive advanced breast cancers
The FDA approved Truqap plus Faslodex for the treatment of metastatic hormone receptor-positive (HR-positive), HER2-negative breast cancer that returned or worsened after treatment with hormone therapy. The approval is for treating cancers in people whose tumors had a mutation in one of three genes. For people with one of these mutations, Truqap improved the time until their cancer came back or got worse. (Posted 2/9/24)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Most relevant for: People interested in genetic testing.
Article: Genetic testing and the future of medicine
An article published in Katie Couric Media discusses genetic testing and how it can impact health. The author talked with Dr. Robert Steiner, a doctor who specializes in genetics. He talked about genetic testing and how the results can affect health and change lives. (Posted 9/28/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-Low
Most relevant for: People with solid tumors.
Article: Promising drug for cancer treatment begins clinical trials
Researchers at City of Hope are testing a new type of cancer treatment drug. When tested in animals and cells taken from human cancers, this new drug prevented the growth of many types of cancer. Initial clinical trials in people have just started. (Posted 9/7/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium-High
Most relevant for: People with breast cancer or metastatic breast cancer in sexual or intimate relationships and their partners
Topic: Sex and intimacy after breast cancer
A breast cancer diagnosis and treatment can affect relationships with romantic partners. This review highlights two studies that looked at how people with breast cancer and their partners are affected, how they cope, how best to communicate with each other and how to talk with healthcare providers about concerns related to cancer and sexuality. (Posted 8/8/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: Medium
Most relevant for: People who have cancer who are pregnant
Topic: Impact of new laws on cancer treatment during pregnancy
The U.S. Supreme Court ruled in 2022 that abortion is no longer a protected right under the Constitution. This landmark decision leaves regulation of abortion to the states. Cancer treatment during pregnancy may now be impacted in states that have abortion bans or limitations. (Posted 5/31/23)
Este artículo está disponible en español.
READ MORE ›
Relevance: High
Most relevant for: People with HR-positive HER2-negative advanced breast cancer
Study: Breast cancer outcomes improved with CDK4/6 inhibitor treatment
A study showed that people with metastatic breast cancer who took an oral drug known as a CDK4/6 inhibitor combined with hormone therapy did better than people who took hormone therapy alone. The drug combination improved the length of time before cancer worsened or returned. After six years of treatment, people who took this drug combination lived longer compared to those who took hormone therapy alone. (Posted 4/5/23)
Este artículo está disponible en español.
READ MORE ›